First-trimester prediction of preterm prelabour rupture of membranes incorporating cervical length measurement

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Dokumenter

  • Fulltext

    Forlagets udgivne version, 405 KB, PDF-dokument

Objectives: To examine early pregnancy risk factors for preterm prelabour rupture of membranes (PPROM) and develop a predictive model. Study design: Retrospective analysis of a cohort of mixed-risk singleton pregnancies screened in the first and second trimesters in three Danish tertiary fetal medicine centres, including a cervical length measurement at 11–14 weeks, at 19–21 weeks and at 23–24 weeks of gestation. Univariable and multivariable logistic regression analyses were employed to identify predictive maternal characteristics, biochemical and sonographic factors. Receiver operating characteristic (ROC) curve analysis was used to determine predictors for the most accurate model. Results: Of 3477 screened women, 77 (2.2%) had PPROM. Maternal factors predictive of PPROM in univariable analysis were nulliparity (OR 2.0 (95% CI 1.2–3.3)), PAPP-A < 0.5 MoM (OR 2.6 (1.1–6.2)), previous preterm birth (OR 4.2 (1.9–8.9)), previous cervical conization (OR 3.6 (2.0–6.4)) and cervical length ≤ 25 mm on transvaginal imaging (first-trimester OR 15.9 (4.3–59.3)). These factors all remained statistically significant in a multivariable adjusted model with an AUC of 0.72 in the most discriminatory first-trimester model. The detection rate using this model would be approximately 30% at a false-positive rate of 10%. Potential predictors such as bleeding in early pregnancy and pre-existing diabetes mellitus affected very few cases and could not be formally assessed. Conclusions: Several maternal characteristics, placental biochemical and sonographic features are predictive of PPROM with moderate discrimination. Larger numbers are required to validate this algorithm and additional biomarkers, not currently used for first-trimester screening, may improve model performance.

OriginalsprogEngelsk
TidsskriftEuropean Journal of Obstetrics and Gynecology and Reproductive Biology
Vol/bind284
Sider (fra-til)76-81
Antal sider6
ISSN0301-2115
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
Olav Bjørn Petersen holds a professorship funded by Novo Nordisk Foundation (grant NNFSA170030576).

Funding Information:
Funding was provided by The Obel Family Fund, The A.P. Moeller Foundation, The King Christian X Foundation, The Heinrich Kopps grant, and The Faculty of Health and Medical Sciences, University of Copenhagen.

Publisher Copyright:
© 2023 The Authors

ID: 341878743